Efficacy of Certolizumab Pegol for Psoriasis of the Head and Neck in Two Phase 3 Clinical Trials: CIMPASI-1 and CIMPASI-2. J of Skin. 2019;3:S40. doi:10.25251/skin.3.supp.40